Insulet (PODD) Net Margin Growth (1y) (2011 - 2026)
Insulet (PODD) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 67.00 |
| 10 | Insulet | 10.18 Bn | 9.64 Bn | 562.60 Mn | 838.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 838.00 |
| Mar 31, 2026 | 572.00 |
| Dec 31, 2025 | -388.00 |
| Sep 30, 2025 | -185.00 |
| Jun 30, 2025 | -3,514.00 |
| Mar 31, 2025 | -542.00 |
| Dec 31, 2024 | -343.00 |
| Sep 30, 2024 | 225.00 |
| Jun 30, 2024 | 3,172.00 |
| Mar 31, 2024 | 501.00 |
| Dec 31, 2023 | 1,568.00 |
| Sep 30, 2023 | 1,352.00 |
| Jun 30, 2023 | 1,858.00 |
| Mar 31, 2023 | -276.00 |
| Dec 31, 2022 | -489.00 |
| Sep 30, 2022 | -634.00 |
| Jun 30, 2022 | -207.00 |
| Dec 31, 2021 | 1,644.00 |
| Sep 30, 2021 | -14.00 |
| Jun 30, 2021 | -1,598.00 |